“…On the other hand, we noticed that the rapid mRNA turnover of LDLR and, to a lesser extent, of HMGCR was stabilized by the addition of 5-AzaC (Fig. 2C), similar to the effect of berberine, a cholesterol-lowering compound (30). Consequently, in human hepatoma HepG2 and Huh-7 cell lines, LDLR protein was strongly up-regulated by 5-AzaC concomitantly to the reduction of PCSK9 (Fig.…”
Background:The anticancer drug 5-azacytidine acts through an incompletely understood mechanism. Results: 5-Azacytidine reprograms the glycerolipid biosynthesis pathway and prevents activation of master transcription factors that regulate lipid homeostasis. Conclusion: 5-Azacytidine deeply modifies how cells manage cholesterol and lipid synthesis. Significance: The findings unravel important insights into the mechanism of 5-azacytidine and highlight new potential cancer therapeutics.
“…On the other hand, we noticed that the rapid mRNA turnover of LDLR and, to a lesser extent, of HMGCR was stabilized by the addition of 5-AzaC (Fig. 2C), similar to the effect of berberine, a cholesterol-lowering compound (30). Consequently, in human hepatoma HepG2 and Huh-7 cell lines, LDLR protein was strongly up-regulated by 5-AzaC concomitantly to the reduction of PCSK9 (Fig.…”
Background:The anticancer drug 5-azacytidine acts through an incompletely understood mechanism. Results: 5-Azacytidine reprograms the glycerolipid biosynthesis pathway and prevents activation of master transcription factors that regulate lipid homeostasis. Conclusion: 5-Azacytidine deeply modifies how cells manage cholesterol and lipid synthesis. Significance: The findings unravel important insights into the mechanism of 5-azacytidine and highlight new potential cancer therapeutics.
“…PCSK9 gene expression can be induced by insulin and pioglitazone and also can be suppressed by glucagon, bile acids, berberine, fibrate, and oncostatin M (22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32). PCSK9 protein levels decrease in the course of fasting and increase after feeding (22,27,29,(32)(33)(34).…”
Background: PCSK9 is critical for LDL-cholesterol regulation, but the epigenetic regulation of the PCSK9 gene is not clear. Results: FoxO3 and Sirt6 suppress the PCSK9 gene expression and reduce LDL-cholesterol. Conclusion: Hepatic FoxO3 and Sirt6 control LDL-cholesterol homeostasis. Significance: FoxO3 and Sirt6 are important for cardiovascular health.
“…However, it was reported that berberine, a natural product, dramatically reduced PCSK9 expression through transcriptional repression (Cameron et al, 2008;Li et al, 2009). While the mechanism is not entirely understood, this observation suggests the possibility that developing small molecule modulators to mediate PCSK9 expression is potentially viable.…”
Section: Novel Regulators Of Low-density Lipoprotein Receptor and Cirmentioning
confidence: 98%
“…In the clinic, however, the majority of available data point to the fact that fibrates significantly elevate PCSK9 levels in both diabetic and non-diabetic subjects, which possibly attenuates fibrate effects in reducing LDL-C levels (Konrad et al, 2011). Berberine, a compound that reduces LDL-C in humans and is derived from a Chinese herb (Coptis sinensis), dramatically reduces PCSK9 mRNA and protein expression in cultured hepatoma cells (Cameron et al, 2008). PCSK9 is regulated by several hormones.…”
Section: Human Genetics Physiology and Regulation Of Pcsk9mentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.